Jun 24, 2026 07:05AM
Jun 24, 2026 07:05AM
Jun 11, 2026 07:05AM
Jun 11, 2026 07:05AM
May 13, 2026 08:30AM
May 12, 2026 07:05AM
May 12, 2026 07:05AM Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
May 5, 2026 07:05AM
Apr 29, 2026 04:05PM
Apr 23, 2026 06:15AM
Mar 26, 2026 07:05AM
Mar 26, 2026 07:05AM
Feb 11, 2026 04:16PM
Jan 12, 2026 07:00AM Viking Therapeutics publishes Phase 2 obesity trial results in Obesity journal
Jan 12, 2026 07:00AM
Jan 8, 2026 07:07AM
Jan 8, 2026 07:00AM
Nov 19, 2025 02:55AM
Nov 19, 2025 02:55AM
Nov 6, 2025 07:05AM
Nov 6, 2025 07:05AM Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek® 2025
Oct 29, 2025 04:05PM
Oct 23, 2025 02:54AM
Oct 22, 2025 04:05PM
Oct 21, 2025 07:05AM
Oct 21, 2025 07:05AM
Sep 14, 2025 08:00PM
Aug 19, 2025 07:09AM Viking Therapeutics reports weight loss results from VK2735 oral trial
Aug 19, 2025 07:08AM
Jul 23, 2025 04:05PM
Jun 25, 2025 10:13AM
Jun 25, 2025 07:03AM
Apr 23, 2025 04:05PM
Mar 26, 2025 07:05AM
Mar 11, 2025 07:03AM Viking Therapeutics (VKTX) Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
Mar 11, 2025 07:03AM
Feb 5, 2025 04:05PM
Jan 8, 2025 07:03AM
Jan 8, 2025 07:03AM
Nov 22, 2024 02:25AM
Nov 7, 2024 07:00AM
Nov 4, 2024 06:30AM Viking Therapeutics (VKTX) Reports New Data from VK2735 Obesity Program
Nov 4, 2024 06:30AM
Oct 28, 2024 04:05PM
Oct 23, 2024 04:05PM
Aug 6, 2024 04:01PM
Jul 24, 2024 04:33PM
Jul 24, 2024 04:05PM
May 7, 2024 04:00PM Ligand Reports First Quarter 2024 Financial Results
Apr 24, 2024 04:05PM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All